Venrock Healthcare Capital Partners II L.P. 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:19 pm Purchase | 2021-03-26 | 13G | Relmada Therapeutics, Inc. RLMD | Venrock Healthcare Capital Partners II L.P. | 2,270,072 8.200% | 1,601,632 (+239.61%) | Filing |
| 2021-02-16 4:10 pm Sale | 2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Venrock Healthcare Capital Partners II L.P. | 668,440 4.100% | -214,374 (-24.28%) | Filing |